(Q39284812)

English

Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model

scientific article published on November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Immunization with Leishmania vaccine-alum-BCG and montanide ISA 720 adjuvants induces low-grade type 2 cytokines and high levels of IgG2 subclass antibodies in the vervet monkey (Chlorocebus aethiops) model (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

1 reference

based on heuristic

inferred from title

object named as

Chlorocebus aethiops

1 reference

based on heuristic

inferred from title

author name string

J M Mutiso

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J C Macharia

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

M M Gicheru

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Scandinavian Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

471-477

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Interleukin 10 production correlates with pathology in human Leishmania donovani infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Lymphokine control of in vivo immunoglobulin isotype selection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Class and subclass selection in parasite-specific antibody responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Antibody isotypes in human schistosomiasis mansoni

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

The profile of IgG and IgG subclasses of onchocerciasis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Visceral leishmaniasis in Somalia. Significance of IgG subclasses and of IgE response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (Chlorocebus aethiops).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

A review of adjuvants for Leishmania vaccine candidates

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

CD8 cytotoxic T cells in cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Requirements for Th1-dependent immunity against infection with Leishmania major

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Safety evaluation of monophosphoryl lipid A (MPL): an immunostimulatory adjuvant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2012.02764.X

21 January 2018

Identifiers

10.1111/J.1365-3083.2012.02764.X

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39284812&oldid=1818230112"